ECHA Weekly: Restriction proposal on chromium(VI) substances to protect health
Please find the information here.
Ben KempMay 9, 2025
Open Forum: Usability Testing Q&A
Wednesday, May 21, 2025 | 9:00 AM 10:00 AM CST Join our subject matter experts, Allison Strochlic, Senior Research Director, Andrea Sutton, Research Director, and Petra Boeree, Lead Human Factors Specialist from Emergo by UL’s Human Factors Research & Design team on May 21, 2025 from 9:00 – 10:00 a.m. CST as they hold an open forum to answer your…
Ben KempMay 9, 2025
New Irish Sea border rules for parcels come into effect
New rules for businesses in Britain posting parcels to Northern Ireland have come into effect. The changes are a consequence of Northern Ireland's post-Brexit deal known as the Windsor Framework. The major change is for business-to-business parcels which now require customs declarations. Parcel companies need to be signed up to a trusted trader scheme but individuals posting and receiving parcels should…
Ben KempMay 9, 2025
Media Monitoring: 1st May – 8th May
NHS England (NHSE) has published new guidance setting out how clinical digital systems can support optimal antimicrobial stewardship (AMS) within healthcare organisations BSAC welcomes this important development and looks forward to seeing how this vision will be translated into Trust-level work plans that are properly resourced and coordinated. BSAC also acknowledges this guidance will be useful, and should be…
Ben KempMay 8, 2025
UKHSA X-ray Irradiated Pathogen Reagents: A Game-Changer for Diagnostic Development
The UK Health Security Agency (UKHSA) is excited to announce the availability of its innovative X-ray irradiated pathogen reagents service, offering a unique solution to one of the most significant challenges facing scientists today: safe access to high-consequence pathogens. Overcoming Containment Barriers in Diagnostic Development Working with high-risk pathogens typically requires specialised containment facilities (Hazard Group 3 or 4), which…
Ben KempMay 8, 2025
AMR National Action Plan – where are we one year on?
The UK 2024 - 2029 National Action Plan on AMR was released on 8th May 2024 — so what progress has been made in a year? While progress has been made in some areas, namely reduced antibiotic usage in agriculture and the launch of the 'Netflix-style' antibiotics subscription model, efforts to utilise diagnostics have been lacking. Four years still remain…
Ben KempMay 6, 2025
UK-India trade agreement finalised
After years of negotiations, the landmark UK-India trade deal has been finalised. For our industry, we welcome the reduction of tariffs and rules of origin on medical devices, making it easier for BIVDA members to export to India, and access to billions of pounds worth of tenders for UK companies. Indian tariffs will now be slashed across the board, locking…
Ben KempMay 6, 2025
The War in Ukraine: the AMR problem
Amidst the ceaseless bloodshed and tragedy endured by the Ukrainian army, a health challenge of international concern continues to fester. This is, of course, in reference to the most fearsome acronym in global health: AMR. The health systems across Ukraine, overwhelmed by the wounded and maimed, provide the unfortunately fertile ground for accelerated antimicrobial resistance. Increased use of antibiotics with…
Ben KempMay 6, 2025
BIVDA community diagnostics report raised in Parliamentary question
We are pleased to announce that, after writing to the foreword to our recent consensus statement on community diagnostics, Exeter's Labour MP Steve Race asked the following question in Parliament: "To ask the Secretary of State for Health and Social Care, with reference to the report by the British In Vitro Diagnostics Association entitled Unlocking our communities diagnostic potential: the…
Ben KempMay 6, 2025